Evolving spectrum and incidence of non-AIDS-defining malignancies.

Department of Pathology, Baystate Medical Center, Tufts University School of Medicine, Springfield, MA, USA.
Current opinion in HIV and AIDS (Impact Factor: 4.39). 02/2009; 4(1):27-34. DOI: 10.1097/COH.0b013e32831a7259
Source: PubMed

ABSTRACT Non-AIDS defining cancer (NADC) has emerged as an important cause of morbidity and mortality in the HIV-infected population. Insight into the incidence, spectrum, risk factors, management, and outcome of these cancers has continued to emerge. The recent literature on this topic is reviewed.
Several recent studies have explored the shifting spectrum of NADC in both developed and underdeveloped regions of the world. Investigators have shown only a minor difference in the geographic spectrum of NADC. Although several NADC have continued to occur at rates significantly higher than expected, a noticeable decline was observed in other cancers despite antiretroviral therapy. Factors other than HIV and immunosuppression proved to be important in the risk, treatment response, and outcome of these neoplasms. Studies dealing with the management of several NADC were published, including the role of highly active antiretroviral therapy (HAART).
An increased overall relative risk of developing NADC continues to be reported in the HIV-infected population worldwide. The development of NADC appears to be multifactorial. Although control of HIV viremia has proven to be beneficial, the impact of HAART on NADC incidence rates and survival is not uniform. Further effort is needed to resolve the direct and indirect effects of HIV on NADC in order to guide effective prevention and treatment strategies of these malignancies.

Download full-text


Available from: Liron Pantanowitz, Apr 28, 2014
  • Source
    • "Epidemiological studies have demonstrated a combination of HIV-specific risk factors such as a CD4 T-cell count of ≤200 ␮L, duration of HIV infection and interruptions in HAART. In addition, traditional risk factors predisposing to malignancy, including risky sexual behaviors , smoking, sun exposure, infection with other oncogenic viruses as well as a familial history of cancer, likely play significant roles [8] [10] "
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV & AIDS Review j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / h i v a r a b s t r a c t Following the widespread use of HAART, malignancy now accounts for nearly 30% of all HIV deaths. Non-AIDS defining malignancies (NADMs) make up a large proportion of this burden, however, AIDS-defining malignancies (ADM) such as non-Hodgkin's Lymphoma (NHL) still makes up nearly 10% of all HIV-deaths. Following recent reclassification by the WHO, Primary effusion lymphoma (PEL), plasmablas-tic and lymphoma arising in HHV8-associated Castleman's disease make up the lymphomas that occur more frequently in the setting of HIV infection. PEL also referred to as body cavity based lymphoma, accounts for 4% of all HIV associated NHL. PEL presents as malignant effusions of the pleura, pericardium or peritoneum without lymphadenopathy. The pathogenesis is through malignant conversion of lym-phoid cells by human herpes virus 8, and evidence of this virus is essential for diagnosis. Other key criteria include presence of common leukocyte marker CD45, but absence of common T-cell and B-cell markers. Prognosis is poor despite treatment with median survival being about 6 months. Standard treatment includes continuation or initiation of HAART and CHOP-like chemotherapy regimens. Novel therapies including use of rituximab, or autologous cell transplant have been used with mixed results. Our case highlights the need to be vigilant when assessing HIV patients with Kaposi's sarcoma for the presence of PEL.
    12/2011; 10:87-90. DOI:10.1016/j.hivar.2011.10.003
  • [Show abstract] [Hide abstract]
    ABSTRACT: The analysis of endocardial borders by Acoustic Quantification (AQ) of 2D echocardiographic images is limited by the presence of random high frequency noise. Using 1D filtration in the Fourier domain we have shown previously that smoothing of AQ images improves signal-to-noise ratio. In this paper we have extended the study by applying 2D Fourier filtration (spatial and temporal) to the AQ borders, and study which of the two sampling methods, Polar or Cartesian sampling, yields a more accurate representation. Various image processing techniques including region labeling, thresholding, edge detection, and area fill algorithms along with 2D-DFT and Hanning filters were used to process the images. Using the original AQ as the gold standard, our results favor Cartesian sampling over Polar sampling
    Computers in Cardiology 1994; 10/1994
  • [Show abstract] [Hide abstract]
    ABSTRACT: High frequency second harmonic imaging was compared with fundamental imaging when highly reflective stents were present in the near field of a spherically focused PVDF transducer. Hydrophone measurements of the harmonic beam at 40 MHz showed a relative lower signal strength in the near field compared to the fundamental modes at 20 and 40 MHz. The beam width (-3dB) of the fundamental 40 MHz and the harmonic 40 MHz, measured in the focal plane were both 80 microns. It was found that harmonic 40 MHz imaging mode suppressed reverberations from the stent by up to 14 dB compared to fundamental 20 MHz imaging.
    Ultrasonics, 2003 IEEE Symposium on; 11/2003
Show more